Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 41.

Franzen, Daniel; Schad, Karin; Kowalski, Benedikt; Clarenbach, Christian F; Stupp, Roger; Dummer, Reinhard; Kohler, Malcolm (2017). Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study. Cancer Immunology, Immunotherapy:Epub ahead of print.

Canella, Claudia; Mikolasek, Michael; Rostock, Matthias; Beyer, Jörg; Guckenberger, Matthias; Jenewein, Josef; Linka, Esther; Six, Claudia; Stoll, Sarah; Stupp, Roger; Witt, Claudia M (2017). Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement – A Qualitative Study. Integrative cancer therapies:Epub ahead of print.

Weller, Michael; Butowski, Nicholas; Tran, David D; Recht, Lawrence D; Lim, Michael; Hirte, Hal; Ashby, Lynn; Mechtler, Laszlo; Goldlust, Samuel A; Iwamoto, Fabio; Drappatz, Jan; O'Rourke, Donald M; Wong, Mark; Hamilton, Mark G; Finocchiaro, Gaetano; Perry, James; Wick, Wolfgang; Green, Jennifer; He, Yi; Turner, Christopher D; Yellin, Michael J; Keler, Tibor; Davis, Thomas A; Stupp, Roger; Sampson, John H; ACT IV trial investigators (2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncology, 18(10):1373-1385.

van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; et al; Stupp, Roger (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet, 390(10103):1645-1653.

Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.

Weller, Michael; van den Bent, Martin; Tonn, Jörg C; Stupp, Roger; Preusser, Matthias; Cohen-Jonathan-Moyal, Elizabeth; Henriksson, Roger; Le Rhun, Emilie; Balana, Carmen; Chinot, Olivier; Bendszus, Martin; Reijneveld, Jaap C; Dhermain, Frederic; French, Pim; Marosi, Christine; Watts, Colin; Oberg, Ingela; Pilkington, Geoffrey; Baumert, Brigitta G; Taphoorn, Martin J B; Hegi, Monika; Westphal, Manfred; Reifenberger, Guido; Soffietti, Riccardo; Wick, Wolfgang; European Association for Neuro-Oncology (EANO) (2017). Evidence-based management of adult patients with diffuse glioma - Authors' reply. Lancet Oncology, 18(8):e430-e431.

Weller, Michael; van den Bent, Martin; Tonn, Jörg C; Stupp, Roger; Preusser, Matthias; Cohen-Jonathan-Moyal, Elizabeth; Henriksson, Roger; Le Rhun, Emilie; Balana, Carmen; Chinot, Olivier; Bendszus, Martin; Reijneveld, Jaap C; Dhermain, Frederick; French, Pim; Marosi, Christine; Watts, Colin; Oberg, Ingela; Pilkington, Geoffrey; Baumert, Brigitta G; Taphoorn, Martin J B; Hegi, Monika; Westphal, Manfred; Reifenberger, Guido; Soffietti, Riccardo; Wick, Wolfgang; European Association for Neuro-Oncology (EANO) (2017). European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncology, 18(6):e315-e329.

Silginer, Manuela; Weller, Michael; Stupp, Roger; Roth, Patrick (2017). Biological activity of tumor-treating fields in preclinical glioma models. Cell Death and Disease, 8(4):e2753.

Maul, Julia-Tatjana; Stenner-Liewen, Frank; Seifert, Burkhardt; Pfrommer, Sarah; Petrausch, Ulf; Kiessling, Michael K; Schanz, Urs; Nair, Gayathri; Mischo, Axel; Taverna, Christian; Schmidt, Adrian; Bargetzi, Mario; Stupp, Roger; Renner, Christoph; Samaras, Panagiotis (2017). Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients. Journal of clinical apheresis, 32(1):21-26.

Kroeze, Stephanie G C; Fritz, Corinna; Hoyer, Morten; Lo, Simon S; Ricardi, Umberto; Sahgal, Arjun; Stahel, Rolf; Stupp, Roger; Guckenberger, Matthias (2016). Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review. Cancer Treatment Reviews, 53:25-37.

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Limani, Perparim; Linecker, Michael; Kron, Philipp; Samaras, Panagiotis; Pestalozzi, Bernhard; Stupp, Roger; Jetter, Alexander; Dutkowski, Philipp; Müllhaupt, Beat; Schlegel, Andrea; Nicolau, Claude; Lehn, Jean-Marie; Petrowsky, Henrik; Humar, Bostjan; Graf, Rolf; Clavien, Pierre-Alain (2016). Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial. BMC Cancer, 16(1):812.

Hottinger, Andreas F; Pacheco, Patricia; Stupp, Roger (2016). Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro-Oncology, 18(10):1338-1349.

Roodakker, Kenney R; Elsir, Tamador; Edqvist, Per-Henrik D; Hägerstrand, Daniel; Carlson, Joseph; Lysiak, Malgorzata; Henriksson, Roger; Pontén, Fredrik; Rosell, Johan; Söderkvist, Peter; Stupp, Roger; Tchougounova, Elena; Nistér, Monica; Malmström, Annika; Smits, Anja (2016). PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. OncoTarget, 7(45):72431-72442.

Stupp, Roger; Toms, Steven A; Kesari, Santosh (2016). Treatment for patients with newly diagnosed glioblastoma--reply. JAMA : the Journal of the American Medical Association, 315(21):2348-2349.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A; Kesari, Santosh; Steinberg, David M; Toms, Steven A; Taylor, Lynne P; Lieberman, Frank; Silvani, Antonio; Fink, Karen L; Barnett, Gene H; Zhu, Jay-Jiguang; Henson, John W; Engelhard, Herbert H; Chen, Thomas C; Tran, David D; Sroubek, Jan; Tran, Nam D; Hottinger, Andreas F; Landolfi, Joseph; Desai, Rajiv; Caroli, Manuela; Kew, Yvonne; Honnorat, Jerome; Idbaih, Ahmed; Kirson, Eilon D; Weinberg, Uri; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2015). Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA : the Journal of the American Medical Association, 314(23):2535-2543.

Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Samaras, Panagiotis; Pfrommer, Sarah; Seifert, Burkhardt; Petrausch, Ulf; Mischo, Axel; Schmidt, Adrian; Schanz, Urs; Nair, Gayathri; Bargetzi, Mario; Taverna, Christian; Stupp, Roger; Stenner-Liewen, Frank; Renner, Christoph (2015). Efficacy of vinorelbine plus G-CSF for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Biology of Blood and Marrow Transplantation, 21(1):74-80.

De Meyer, Tim; Bady, Pierre; Trooskens, Geert; Kurscheid, Sebastian; Bloch, Jocelyne; Kros, Johan M; Hainfellner, Johannes A; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E; Van Criekinge, Wim (2015). Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. Scientific Reports, 5:15375.

Dirven, Linda; Taphoorn, Martin J B; Reijneveld, Jaap C; Blazeby, Jane; Jacobs, Marc; Pusic, Andrea; La Sala, Edoardo; Stupp, Roger; Fayers, Peter; Efficace, Fabio (2014). The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review. European Journal of Cancer, 50(14):2432-2448.

Lacombea, Denis; Burocka, Susen; Bogaertsa, Jan; Schoeffskib, Patrick; Golfinopoulosa, Vassilis; Stupp, Roger (2014). The dream and reality of histology agnostic cancer clinical trials. Molecular Oncology, 8(6):1057-1063.

Liu, Yan; Lacombe, Denis; Stupp, Roger (2014). The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug development. Chinese Clinical Oncology, 3(2):19.

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

Lacombe, Denis; Tejpar, Sabine; Salgado, Roberto; Cardoso, Fatima; Golfinopoulos, Vassilis; Aust, Daniela; Folprecht, Gunnar; Roth, Arnaud; Stupp, Roger (2014). European perspective for effective cancer drug development. Nature Reviews. Clinical Oncology, 11(8):492-498.

Zikos, Efstathios; Ghislain, Irina; Coens, Corneel; Ediebah, Divine E; Sloan, Elizabeth; Quinten, Chantal; Koller, Michael; van Meerbeeck, Jan P; Flechtner, Hans-Henning; Stupp, Roger; Czimbalmos, Agnes; Sprangers, Mirjam A G; Bottomley, Andrew (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15(2):e78-e89.

Hottinger, Andreas F; Stupp, Roger; Homicsko, Krisztian (2014). Standards of care and novel approaches in the management of glioblastoma multiforme. Chinese Journal of Cancer, 33(1):32-39.

Kondziolka, Douglas; Parry, Phillip V; Lunsford, L Dade; Kano, Hideyuki; Flickinger, John C; Rakfal, Susan; Arai, Yoshio; Loeffler, Jay S; Rush, Stephen; Knisely, Jonathan P S; Sheehan, Jason; Friedman, William; Tarhini, Ahmad A; Francis, Lanie; Lieberman, Frank; Ahluwalia, Manmeet S; Linskey, Mark E; McDermott, Michael; Sperduto, Paul; Stupp, Roger (2014). The accuracy of predicting survival in individual patients with cancer. Journal of Neurosurgery, 120(1):24-30.

Connor, Joseph P; Cristea, Mihaela C; Lewis, Nancy L; Lewis, Lionel D; Komarnitsky, Philip B; Mattiacci, Maria R; Felder, Mildred; Stewart, Sarah; Harter, Josephine; Henslee-Downey, Jean; Kramer, Daniel; Neugebauer, Roland; Stupp, Roger (2013). A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors. BMC Cancer, 13:20.

Stupp, Roger; Hegi, Monika E (2013). Brain cancer in 2012: Molecular characterization leads the way. Nature Reviews. Clinical Oncology, 10(2):69-70.

Doroshow, James H; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth (2013). Cancer clinical trials - do we need a new algorithm in the age of stratified medicine? The oncologist, 18(6):651-652.

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Tabatabai, Ghazaleh; Stupp, Roger; Wick, Wolfgang; Weller, Michael (2013). Malignant astrocytoma in elderly patients: where do we stand? Current Opinion in Neurology, 26(6):693-700.

Jarzabek, Monika A; Sweeney, Kieron J; Evans, Rhys L; Jacobs, Andreas H; Stupp, Roger; O'Brien, Donncha; Berger, Mitchel S; Prehn, Jochen H M; Byrne, Annette T (2013). Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discovery Today, 18(21-22):1052-1066.

Hegi, Monika E; Stupp, Roger (2013). Neuro-oncology: in search of molecular markers of glioma in elderly patients. Nature Reviews. Neurology, 9(8):424-425.

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Laurent, Julien; Touvrey, Cedric; Gillessen, Silke; Joffraud, Magali; Vicari, Manuela; Bertrand, Caroline; Ongarello, Stefano; Liedert, Bernd; Gallerani, Elisa; Beck, Joachim; Omlin, Aurelius; Sessa, Cristiana; Quaratino, Sonia; Stupp, Roger; Gnad-Vogt, Ulrike S; Speiser, Daniel E (2013). T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein. Journal of Translational Medicine, 11:5.

This list was generated on Tue Dec 12 18:53:38 2017 CET.